Envudeucitinib — catalyst calendar

Name: Bio Catalyst Calendar — source-anchored biotech/pharma catalyst dates
Creator: Bio Catalyst Calendar
License: https://www.usa.gov/government-works

1 verified catalyst event(s) referencing Envudeucitinib, each linked to its official source. Verified as of 2026-06-22.

Upcoming

Date	Event	Company	Drug	Official source & verification
2026-07-01 in 9d ESTIMATED	READOUT Phase 2 Placebo-Controlled Study to Assess the Safety and Efficacy of ESK-001 in Phase 2 · SLE	ALMS ALUMIS INC.	Envudeucitinib	ClinicalTrials.gov ↗ ✓ Source-checked 2026-06-22 Sponsor-projected date — can change

Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.